Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Title
Intervention Indication Therapeutic Area Year Actions
Futibatinib for treating cholangiocarcinoma with FGFR2 gene rearrangements Futibatinib Cholangiocarcinoma Haematological Cancer and Lymphomas , Oncology 2023 View  |  Download
Infigratinib for unresectable locally advanced or metastatic cholangiocarinoma with FGFR2 rearrangements – second line Infigratinib (BGJ398; BGJ-398; Truseltiq) Cholangiocarcinoma Gastrointestinal Cancer 2021 View  |  Download
Ivosidenib for previously treated advanced cholangiocarcinoma Ivosidenib (Tibsovo; AG-120) Cholangiocarcinoma Gastrointestinal Cancer 2022 View  |  Download
Pemigatinib for locally advanced or metastatic, relapsed or refractory cholangiocarcinoma with FGFR2 fusion or rearrangement Pemigatinib (INCB054828) Cholangiocarcinoma Gastrointestinal Cancer 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications